Allergies News and Research

Latest Allergies News and Research

Researchers use new gene editing tool to cut HIV DNA

The virus that causes AIDS is an efficient and crafty retrovirus. Once HIV inserts its DNA into the genome of its host cells, it has a long incubation period, and can remain dormant and hidden for years.

10 Apr 2015

Enhanced biodiversity of worms, germs associated with better immune function, overall health

A growing body of evidence in the medical community holds that greater diversity of bacteria and even worms in the digestive tract offers protection against a variety of allergic and autoimmune problems.

9 Apr 2015

Phase 1 clinical trial: Anti-HIV antibody significantly decreases HIV levels

A single infusion of an experimental anti-HIV antibody called 3BNC117 resulted in significantly decreased HIV levels that persisted for as long as 28 days in HIV-infected individuals, according to Phase 1 clinical trial findings published online today in Nature.

8 Apr 2015

Study: Gene variant, urban environment increase risk of severe disease in children infected with RSV

A particular genetic mutation combined with an urban environment increases the risk of severe disease in children infected with respiratory syncytial virus (RSV), an international team of investigators has found.

8 Apr 2015

MGH investigators identify inflammatory molecule that plays key role in lupus

Massachusetts General Hospital (MGH) investigators have identified an inflammatory molecule that appears to play an essential role in the autoimmune disorder systemic lupus erythematosus, commonly known as lupus.

7 Apr 2015

Scientists identify rhinovirus C receptor associated with severe asthma attacks

Scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have identified a cellular receptor for rhinovirus C, a cold-causing virus that is strongly associated with severe asthma attacks.

6 Apr 2015

Breast milk purchased online has significant amounts of cow's milk added, study finds

A study published today on the safety of human breast milk bought over the Internet found that 10 percent of samples contained added cow's milk. The discovery that purchased samples of human milk may be purposely "topped off" with cow's milk or infant formula confirms a danger for the large number of babies receiving the purchased milk due to medical conditions.

6 Apr 2015

Canada's VSV-EBOV Ebola vaccine proves safe, effective in Phase 1 clinical trial

The Honourable Rona Ambrose, Minister of Health, and Canada's Chief Public Health Officer, Dr. Gregory Taylor, today welcomed the news of promising trial outcomes of Canada's VSV-EBOV Ebola vaccine. The results of several studies and trials bring the world closer to ending this global outbreak through the provision of a commercially available vaccine.

2 Apr 2015

EpiPen (epinephrine) emergency kits now available at Montreal Bell Centre for treating severe allergies

Pfizer Canada Inc., the distributor of EpiPen, and the Montreal Bell Centre are pleased to announce that EpiPen (epinephrine) emergency kits are now available at the Bell Centre, home of the Montreal Canadiens hockey team. The new partnership strives to offer a safeguarded environment for visitors at risk of serious allergic reactions during hockey games, concerts and other entertainment events.

1 Apr 2015

New blood test promises to detect food allergies

A new blood test promises to predict which people will have severe allergic reactions to foods according to a new study led by Mount Sinai researchers and published online today in the The Annals of Allergy, Asthma & Immunology.

1 Apr 2015

Study can aid in developing patient-centered interventions for seniors with asthma

Although often considered a childhood health problem, asthma - a chronic inflammatory disease that causes recurrent cough, wheezing and chest tightness or shortness of breath - can cause serious illness for people age 60 and older, and little is known about the triggers of asthma specific to seniors.

31 Mar 2015

Two experimental Ebola vaccines appear to be safe in PREVAIL clinical trial in Liberia

Two experimental Ebola vaccines appear to be safe based on evaluation in more than 600 people in Liberia who participated in the first stage of the Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) Phase 2/3 clinical trial, according to interim findings from an independent Data and Safety Monitoring Board review.

30 Mar 2015

Promising clinical trial results for ebola vaccines

Interim findings from a clinical trial (PREVAIL) in which two experimental Ebola vaccines were given to more than 600 people in Liberia indicate that the vaccines are safe for use in humans. Based on these positive results, the vaccines may continue into the next stage of clinical evaluation; a phase 3 trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

27 Mar 2015

New Ebola vaccine shows promise in first phase 1 clinical trial

Results from the first phase 1 trial of an Ebola vaccine based on the current (2014) strain of the virus are today published in The Lancet. Until now, all tested Ebola virus vaccines have been based on the virus strain from the Zaire outbreak in 1976. The results suggest that the new vaccine is safe, and provokes an immune response in recipients, although further long-term testing will be needed to establish whether it can protect against the Ebola virus.

27 Mar 2015

Metabolic imbalance can trigger respiratory diseases in early childhood

An imbalance in our metabolism can trigger inflammatory processes in the body and activate the immune system. In a recent study, published in the Journal of Allergy and Clinical Immunology, UFZ researchers have been able to show that this applies even to newborns and children under one year of age, and is correlated with the development of respiratory diseases in early childhood.

26 Mar 2015

Montefiore physician offers tips for seasonal allergy sufferers

This winter was one of the coldest on record, but spring allergy season is already beginning and it's time for sufferers to start preparing now.

23 Mar 2015

Glyxambi for Type 2 diabetes treatment now available by prescription across the U.S.

Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid.

23 Mar 2015

New anti-clotting therapy no better than established anticoagulants

A novel therapy that would allow doctors to turn the body's blood-clotting ability off and on in a more controlled way was about as effective as established anticoagulants in patients undergoing angioplasty but was associated with higher rates of moderate to severe bleeding, according to an analysis of data from a terminated Phase III trial presented at the American College of Cardiology's 64th Annual Scientific Session.

20 Mar 2015

AIR Louisville to use digital health technology to improve asthma

Today marks the start of AIR Louisville, the first-of-its-kind data-driven collaboration among public, private and philanthropic organizations to use digital health technology to improve asthma. Kentucky has the fourth highest adult asthma prevalence in the US and Louisville consistently ranks among the top 20 "most challenging" cities to live in with asthma.

20 Mar 2015

Two common antibiotic treatments equally effective against MRSA skin infections

Researchers funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have found that two common antibiotic treatments work equally well against bacterial skin infections caused by methicillin-resistant Staphylococcus aureus (MRSA) acquired outside of hospital settings.

20 Mar 2015

Allergies News and Research

Latest Allergies News and Research

Researchers use new gene editing tool to cut HIV DNA

Enhanced biodiversity of worms, germs associated with better immune function, overall health

Phase 1 clinical trial: Anti-HIV antibody significantly decreases HIV levels

Study: Gene variant, urban environment increase risk of severe disease in children infected with RSV

MGH investigators identify inflammatory molecule that plays key role in lupus

Scientists identify rhinovirus C receptor associated with severe asthma attacks

Breast milk purchased online has significant amounts of cow's milk added, study finds

Canada's VSV-EBOV Ebola vaccine proves safe, effective in Phase 1 clinical trial

EpiPen (epinephrine) emergency kits now available at Montreal Bell Centre for treating severe allergies

New blood test promises to detect food allergies

Study can aid in developing patient-centered interventions for seniors with asthma

Two experimental Ebola vaccines appear to be safe in PREVAIL clinical trial in Liberia

Promising clinical trial results for ebola vaccines

New Ebola vaccine shows promise in first phase 1 clinical trial

Metabolic imbalance can trigger respiratory diseases in early childhood

Montefiore physician offers tips for seasonal allergy sufferers

Glyxambi for Type 2 diabetes treatment now available by prescription across the U.S.

New anti-clotting therapy no better than established anticoagulants

AIR Louisville to use digital health technology to improve asthma

Two common antibiotic treatments equally effective against MRSA skin infections

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Allergies News and Research

Latest Allergies News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in